Zevra Therapeutics, Inc. (ZVRA) Zevra Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases. The company’s pipeline includes treatments targeting neurological disorders and other unmet medical needs. Zevra leverages its expertise in drug development to bring innovative solutions to patients with limited treatment options. Chart Mirion Technologies, Inc. (MIR) […]
Read MoreNurix Therapeutics, Inc. (NRIX) Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that modulate protein levels to treat cancer and other diseases. The company’s pipeline includes targeted protein degraders and inhibitors, aiming to address unmet medical needs in oncology and immunology. Nurix collaborates with leading pharmaceutical companies to advance its drug […]
Read MoreFeatured Content The healthcare technology and innovation sector is advancing rapidly, with companies like Clover Health Investments (CLOV), Butterfly Network, Inc. (BFLY), and Codexis, Inc. (CDXS) leading the charge in healthcare accessibility, diagnostics, and biopharmaceutical innovation. Clover Health Investments (CLOV) is a health insurance provider that uses technology to improve healthcare access and outcomes. Its […]
Read MoreFeatured Content Delcath Systems, Inc. (DCTH) is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of cancer. Founded in 1988, Delcath specializes in regional chemotherapy systems that deliver high doses of chemotherapy directly to tumors while minimizing systemic exposure and side effects. The company’s flagship product, the Delcath Hepatic Delivery […]
Read MoreFeatured Content TG Therapeutics, Inc. (TGTX) is a biotechnology company focused on developing innovative therapies for the treatment of B-cell diseases, including various forms of cancer and autoimmune disorders. Founded in 2012, the company is committed to advancing the treatment landscape through the development of novel, targeted therapies that aim to improve patient outcomes. TG […]
Read MoreFeatured Content Axogen, Inc. (AXGN) is a leading medical technology company specializing in the development and commercialization of innovative surgical solutions for peripheral nerve injuries. Founded in 2002, Axogen focuses on providing advanced products to help surgeons restore nerve function and improve patient outcomes after traumatic injuries or surgical procedures. The company’s mission is to […]
Read MoreFeatured Content The biopharmaceutical industry continues to play a transformative role in modern healthcare, offering advanced therapies that target complex diseases such as cancer, autoimmune disorders, and genetic conditions. Leveraging the power of biotechnology, the development of biologics, gene therapies, and personalized medicine is accelerating, providing new treatment options that are more targeted and effective […]
Read MoreFeatured Content FTAI Aviation Ltd. (FTAI) This company focuses on aviation leasing and infrastructure solutions, providing aircraft leasing services and engine maintenance. It helps airlines and operators optimize their fleets and manage high-demand aircraft equipment. Inseego Corp. (INSG) Inseego is a leader in 5G and IoT device solutions, offering innovative wireless communication devices. Their technology […]
Read MoreAquestive Therapeutics, Inc. (AQST) Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. Praxis Precision Medicines, Inc. (PRAX) Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. Altimmune, Inc. (ALT) Altimmune, Inc., a clinical stage biopharmaceutical company, focuses […]
Read MoreGeron Corporation (GERN) Focuses on developing and commercializing therapeutic products for oncology, specifically targeting telomerase for cancer treatment. Longboard Pharmaceuticals, Inc. (LBPH) Develops novel therapies for neurological diseases, focusing on rare and high-need conditions with limited treatment options. AZZ Inc. (AZZ) Provides metal coating and electrical systems for the power generation, transmission, and industrial markets. […]
Read MoreQ32 Bio Inc. (QTTB) Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. LendingTree, Inc. (TREE) LendingTree, Inc., through its subsidiary, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. Red […]
Read MoreQ32 Bio Inc. is a biotechnology company focused on developing therapies to treat severe autoimmune and inflammatory diseases. The company leverages its deep understanding of immune system biology to develop novel treatments that address the root causes of these debilitating conditions. Q32 Bio’s pipeline includes both antibody-based therapies and targeted cytokine inhibitors aimed at regulating […]
Read MoreDyne Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing life-transforming therapies for patients with serious muscle diseases. The company’s proprietary FORCE™ platform is designed to deliver targeted therapies to muscle tissue, addressing the underlying genetic causes of debilitating diseases such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular […]
Read MoreSoleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Q32 Bio Inc. (QTTB) Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction […]
Read MoreStoke Therapeutics, Inc. (STOK) is a biotechnology company dedicated to developing innovative treatments for severe genetic diseases. The company’s unique approach focuses on RNA-based medicines that can precisely target and correct the underlying genetic causes of diseases. Stoke’s lead program, STK-001, aims to treat Dravet syndrome, a severe and progressive form of epilepsy. By leveraging […]
Read More